cirrhosis treatment

Is telmisartan effective in treating non-alcoholic steatohepatitis?

harminka — Tue, 03 Mar 2009 11:39:21 -0600

Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are well-recognized causes of progressive liver disease leading to cirrhosis and hepatocellular carcinoma.

How to save cost for esophageal varices?

harminka — Wed, 21 May 2008 10:39:34 -0500

Patients with cirrhosis of the liver develop abnormally dilated blood vessels in esophagus. These are called esophageal varices. Blood vomiting may occur from the rupture of these varices, which may be fatal, so it is important to eradicate these varices.

Serum fibrosis markers correlate with liver fibrosis stage in patients with hepatitis C

harminka — Mon, 03 Mar 2008 13:20:00 -0600

A prospective study of patients with advanced chronic hepatitis C (CHC) revealed that a 3-variable model of serum fibrosis markers, including serum HA, TIMP-1 and platelet count, could identify cirrhosis with better accuracy than other published models.

Cause of effectiveness discovered for cirrhosis treatment

harminka — Wed, 27 Feb 2008 12:41:26 -0600

Scientists of the Center for Applied Medical Research (CIMA) of the University of Navarra have discovered the molecular mechanism responsible for the effectiveness of an existing treatment for primary biliary cirrhosis, which combines two substances in order to produce an effect that does not result from either substance separately

Ligation is cost-effective if quality of life-years are considered

harminka — Mon, 02 Apr 2007 12:38:47 -0500

Endoscopic variceal ligation is cost-effective relative to beta-blockers for the prevention of variceal bleeding in cirrhotic patients if quality of life-years are considered. If only life-years are considered, then endoscopic variceal ligation is not cost-effective.